HIGHLIGHTS
- who: Hilario Blasco-Fontecilla from the Department of Psychiatry, Segovia Arana Health Research Institute (IDIPHISA)-Puerta Hierro University Madrid, Spain have published the paper: Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders, in the Journal: (JOURNAL) of May/25,/2017
- what: The authors report the proportion of patients achieving clinical amelioration of side effects and changes in number of drugs. The aim of this study was to describe the clinical utility of Neuropharmagen for children with severe mental disorders under real-world conditions.
- how: The results are in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.